KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Goodwill (2016 - 2026)

Medtronic (MDT) has disclosed Goodwill for 14 consecutive years, with $41.9 billion as the latest value for Q1 2026.

  • Quarterly Goodwill rose 2.63% to $41.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $41.9 billion through Jan 2026, up 2.63% year-over-year, with the annual reading at $41.7 billion for FY2025, 1.83% up from the prior year.
  • Goodwill hit $41.9 billion in Q1 2026 for Medtronic, roughly flat from $41.8 billion in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $42.0 billion in Q3 2025 to a low of $66.0 million in Q3 2022.
  • Historically, Goodwill has averaged $29.3 billion across 5 years, with a median of $41.0 billion in 2024.
  • Biggest five-year swings in Goodwill: plummeted 99.84% in 2022 and later soared 62263.64% in 2024.
  • Year by year, Goodwill stood at $66.0 million in 2022, then soared by 61750.0% to $40.8 billion in 2023, then rose by 0.83% to $41.2 billion in 2024, then grew by 1.58% to $41.8 billion in 2025, then increased by 0.19% to $41.9 billion in 2026.
  • Business Quant data shows Goodwill for MDT at $41.9 billion in Q1 2026, $41.8 billion in Q4 2025, and $42.0 billion in Q3 2025.